Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant
DrugDrug NameDrug Description
DB00105Interferon Alfa-2b, RecombinantInterferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1Active Not Recruiting1
DB11595Atezolizumab1Recruiting2
DB05239Cobimetinib1Active Not Recruiting2
DB05239Cobimetinib1Recruiting1
DB00531Cyclophosphamide1Completed1
DB00531Cyclophosphamide1Recruiting1
DB12213Etaracizumab1Completed1
DB01073Fludarabine1Recruiting1
DB00724Imiquimod1Completed1
DB06186Ipilimumab1Active Not Recruiting1
DB06186Ipilimumab1Completed2
DB06186Ipilimumab1Terminated1
DB00480Lenalidomide1Completed1
DB00745Modafinil1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB06132Nivolumab1Completed1
DB09035Nivolumab1Completed2
DB09035Nivolumab1Recruiting1
DB06603Panobinostat1Completed1
DB09037Pembrolizumab1Active Not Recruiting1
DB00073Rituximab1Recruiting1
DB00020Sargramostim1Completed1
DB11689Selumetinib1Completed1
DB05238Vemurafenib1Active Not Recruiting1
DB08881Vemurafenib1Active Not Recruiting3
DB08881Vemurafenib1Completed4
DB08881Vemurafenib1Terminated1
DB00541Vincristine1Completed1
DB131014SC-2021 / 2Not Yet Recruiting1
DB05103AN-91 / 2Terminated1
DB00041Aldesleukin1 / 2Recruiting1
DB00041Aldesleukin1 / 2Terminated1
DB11967Binimetinib1 / 2Not Yet Recruiting1
DB05806Cositecan1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Unknown Status1
DB00851Dacarbazine1 / 2Completed2
DB01262Decitabine1 / 2Completed1
DB01073Fludarabine1 / 2Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB05003Imexon1 / 2Completed1
DB06186Ipilimumab1 / 2Active Not Recruiting1
DB01229Paclitaxel1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Not Yet Recruiting2
DB09037Pembrolizumab1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Withdrawn1
DB13017Rovalpituzumab Tesirine1 / 2Recruiting1
DB00020Sargramostim1 / 2Active Not Recruiting1
DB00020Sargramostim1 / 2Completed1
DB00853Temozolomide1 / 2Completed1
DB04937Tertomotide1 / 2Completed1
DB11771Tremelimumab1 / 2Recruiting1
DB00313Valproic Acid1 / 2Terminated1
DB00459Acitretin2Terminated1
DB00041Aldesleukin2Completed2
DB00041Aldesleukin2Recruiting1
DB11595Atezolizumab2Recruiting1
DB06626Axitinib2Active Not Recruiting1
DB00112Bevacizumab2Completed2
DB01222Budesonide2Completed1
DB11666Buparlisib2Recruiting1
DB05916CT-0112Completed1
DB00958Carboplatin2Active Not Recruiting1
DB05239Cobimetinib2Recruiting2
DB00531Cyclophosphamide2Completed1
DB00531Cyclophosphamide2Recruiting1
DB08912Dabrafenib2Active Not Recruiting1
DB08912Dabrafenib2Recruiting1
DB00851Dacarbazine2Active Not Recruiting1
DB00851Dacarbazine2Completed2
DB00851Dacarbazine2Unknown Status1
DB00004Denileukin diftitox2Completed1
DB05494Elacytarabine2Completed2
DB01073Fludarabine2Completed1
DB01073Fludarabine2Recruiting1
DB04106Fotemustine2Completed1
DB00724Imiquimod2Completed1
DB00028Immune Globulin Human2Unknown Status1
DB00105Interferon Alfa-2b, Recombinant2Withdrawn1
DB06186Ipilimumab2Active Not Recruiting1
DB06186Ipilimumab2Completed2
DB06186Ipilimumab2Recruiting1
DB06186Ipilimumab2Terminated1
DB00125L-Arginine2Completed1
DB01259Lapatinib2Terminated1
DB00227Lovastatin2Withdrawn1
DB09035Nivolumab2Recruiting1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Completed1
DB00022Peginterferon alfa-2b2Completed1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06176Romidepsin2Terminated1
DB00020Sargramostim2Completed2
DB00398Sorafenib2Completed2
DB00853Temozolomide2Active Not Recruiting2
DB00853Temozolomide2Completed1
DB00853Temozolomide2Terminated1
DB00853Temozolomide2Unknown Status1
DB04900Thymalfasin2Completed1
DB08911Trametinib2Active Not Recruiting1
DB08911Trametinib2Recruiting1
DB11771Tremelimumab2Completed1
DB08881Vemurafenib2Completed3
DB08881Vemurafenib2Recruiting2
DB08881Vemurafenib2Terminated2
DB08881Vemurafenib2Unknown Status1
DB00008Peginterferon alfa-2a2 / 3Completed1
DB05239Cobimetinib3Active Not Recruiting1
DB00851Dacarbazine3Completed3
DB04106Fotemustine3Completed1
DB00105Interferon Alfa-2b, Recombinant3Completed1
DB01229Paclitaxel3Completed1
DB08881Vemurafenib3Active Not Recruiting2
DB08881Vemurafenib3Completed2
DB06186Ipilimumab4Active Not Recruiting1
DB08881Vemurafenib4Active Not Recruiting1
DB00041AldesleukinNot AvailableActive Not Recruiting1
DB00099FilgrastimNot AvailableRecruiting1
DB06186IpilimumabNot AvailableNo Longer Available1
DB09035NivolumabNot AvailableNo Longer Available1
DB09037PembrolizumabNot AvailableEnrolling by Invitation1